Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Cited In for PubMed (Select 19726871)

1.

MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction.

Tony H, Yu K, Qiutang Z.

Oxid Med Cell Longev. 2015;2015:597032. Epub 2015 Jun 7.

PMID:
26137188
Free Article
2.

MicroRNA Stability in Postmortem FFPE Tissues: Quantitative Analysis Using Autoptic Samples from Acute Myocardial Infarction Patients.

Kakimoto Y, Kamiguchi H, Ochiai E, Satoh F, Osawa M.

PLoS One. 2015 Jun 5;10(6):e0129338. doi: 10.1371/journal.pone.0129338. eCollection 2015.

3.

Trbp regulates heart function through microRNA-mediated Sox6 repression.

Ding J, Chen J, Wang Y, Kataoka M, Ma L, Zhou P, Hu X, Lin Z, Nie M, Deng ZL, Pu WT, Wang DZ.

Nat Genet. 2015 Jul;47(7):776-83. doi: 10.1038/ng.3324. Epub 2015 Jun 1.

PMID:
26029872
4.

MicroRNAs and Cardiac Regeneration.

Hodgkinson CP, Kang MH, Dal-Pra S, Mirotsou M, Dzau VJ.

Circ Res. 2015 May 8;116(10):1700-11. doi: 10.1161/CIRCRESAHA.116.304377. Review.

PMID:
25953925
5.

Gene Expression Analyses during Spontaneous Reversal of Cardiomyopathy in Mice with Repressed Nuclear CUG-BP, Elav-Like Family (CELF) Activity in Heart Muscle.

Dasgupta T, Coram RJ, Stillwagon SJ, Ladd AN.

PLoS One. 2015 Apr 20;10(4):e0124462. doi: 10.1371/journal.pone.0124462. eCollection 2015.

6.

Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.

Kondkar AA, Abu-Amero KK.

Biomed Res Int. 2015;2015:821823. doi: 10.1155/2015/821823. Epub 2015 Feb 1. Review.

7.

Dawn of the Epi-LncRNAs: new path from Myheart.

Wang Z, Wang Y.

Circ Res. 2015 Jan 16;116(2):235-6. doi: 10.1161/CIRCRESAHA.114.305490. No abstract available.

PMID:
25593274
8.

Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study.

Baán JA, Varga ZV, Leszek P, Kuśmierczyk M, Baranyai T, Dux L, Ferdinandy P, Braun T, Mendler L.

J Transl Med. 2015 Jan 16;13:1. doi: 10.1186/s12967-014-0365-0.

9.

Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.

Huang S, Zou X, Zhu JN, Fu YH, Lin QX, Liang YY, Deng CY, Kuang SJ, Zhang MZ, Liao YL, Zheng XL, Yu XY, Shan ZX.

J Cell Mol Med. 2015 Mar;19(3):608-19. doi: 10.1111/jcmm.12445. Epub 2015 Jan 13.

10.

Heart over mind: metabolic control of white adipose tissue and liver.

Nakamura M, Sadoshima J.

EMBO Mol Med. 2014 Dec 3;6(12):1521-4. doi: 10.15252/emmm.201404749.

11.

From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease.

Sun M, Kraus WL.

Endocr Rev. 2015 Feb;36(1):25-64. doi: 10.1210/er.2014-1034. Epub 2014 Nov 26.

PMID:
25426780
12.

MicroRNAs in heart failure: Small molecules with major impact.

Kalozoumi G, Yacoub M, Sanoudou D.

Glob Cardiol Sci Pract. 2014 Jun 18;2014(2):79-102. doi: 10.5339/gcsp.2014.30. eCollection 2014. Review.

13.

MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis.

Su M, Wang J, Wang C, Wang X, Dong W, Qiu W, Wang Y, Zhao X, Zou Y, Song L, Zhang L, Hui R.

Cell Death Differ. 2015 Jun;22(6):986-99. doi: 10.1038/cdd.2014.187. Epub 2014 Nov 14.

PMID:
25394488
14.

Thyroid Hormone-Regulated Cardiac microRNAs are Predicted to Suppress Pathological Hypertrophic Signaling.

Janssen R, Zuidwijk MJ, Kuster DW, Muller A, Simonides WS.

Front Endocrinol (Lausanne). 2014 Oct 20;5:171. doi: 10.3389/fendo.2014.00171. eCollection 2014.

15.
16.

The association between circulating microRNA levels and coronary endothelial function.

Widmer RJ, Chung WY, Herrmann J, Jordan KL, Lerman LO, Lerman A.

PLoS One. 2014 Oct 13;9(10):e109650. doi: 10.1371/journal.pone.0109650. eCollection 2014.

17.

The protective effect of microRNA-320 on left ventricular remodeling after myocardial ischemia-reperfusion injury in the rat model.

Song CL, Liu B, Diao HY, Shi YF, Li YX, Zhang JC, Lu Y, Wang G, Liu J, Yu YP, Guo ZY, Wang JP, Zhao Z, Liu JG, Liu YH, Liu ZX, Cai D, Li Q.

Int J Mol Sci. 2014 Sep 29;15(10):17442-56. doi: 10.3390/ijms151017442.

18.

RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model.

Aggarwal P, Turner A, Matter A, Kattman SJ, Stoddard A, Lorier R, Swanson BJ, Arnett DK, Broeckel U.

PLoS One. 2014 Sep 25;9(9):e108051. doi: 10.1371/journal.pone.0108051. eCollection 2014.

19.

miR-22 in cardiac remodeling and disease.

Huang ZP, Wang DZ.

Trends Cardiovasc Med. 2014 Oct;24(7):267-72. doi: 10.1016/j.tcm.2014.07.005. Epub 2014 Aug 2. Review.

PMID:
25218673
20.

MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1.

Song L, Su M, Wang S, Zou Y, Wang X, Wang Y, Cui H, Zhao P, Hui R, Wang J.

J Cell Mol Med. 2014 Nov;18(11):2266-74. doi: 10.1111/jcmm.12380. Epub 2014 Sep 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk